We are live on ! Find out more
COYA icon

Coya Therapeutics
COYA

19 hedge funds and large institutions have $21.4M invested in Coya Therapeutics in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $19.8M → $21.4M (+$1.58M)

0.31% more ownership

Funds ownership: 21.47% → 21.78% (+0.31%)

0% more funds holding

Funds holding: 19 → 19 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CM
CM Management
Florida
+$278K
2
GIA
GHP Investment Advisors
Colorado
+$165K
3
Jones Financial Companies
Jones Financial Companies
Missouri
+$38.2K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$28.3K
5
BlackRock
BlackRock
New York
+$7.87K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$68.1K
2
UBS Group
UBS Group
Switzerland
-$64.8K
3
GC
Gilbert & Cook
Iowa
-$60.6K
4
TRCT
Tower Research Capital (TRC)
New York
-$14K
5
Osaic Holdings
Osaic Holdings
Arizona
-$9.26K
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
1
DME Capital Management
New York
$8.22M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.45M – – –
ACM
3
AIGH Capital Management
Maryland
$4.19M – – –
CM
4
CM Management
Florida
$929K +$278K +44,059 +44%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$918K +$28.3K +4,485 +3%
BlackRock
6
BlackRock
New York
$425K +$7.87K +1,248 +2%
State Street
7
State Street
Massachusetts
$277K – – –
PCM
8
Prelude Capital Management
New York
$231K – – –
GIA
9
GHP Investment Advisors
Colorado
$169K +$165K +26,171 New
Northern Trust
10
Northern Trust
Illinois
$164K – – –
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$148K -$68.1K -10,796 -32%
Renaissance Technologies
12
Renaissance Technologies
New York
$111K +$3.15K +500 +3%
MCP
13
Mirador Capital Partners
California
$92K -$2.96K -470 -3%
Jones Financial Companies
14
Jones Financial Companies
Missouri
$40.9K +$38.2K +6,050 New
Osaic Holdings
15
Osaic Holdings
Arizona
$12.1K -$9.26K -1,468 -44%
Morgan Stanley
16
Morgan Stanley
New York
$5.16K – – –
TRCT
17
Tower Research Capital (TRC)
New York
$3.06K -$14K -2,212 -82%
Bank of America
18
Bank of America
North Carolina
$684 -$6 -1 -0.9%
JP Morgan Chase
19
JP Morgan Chase
New York
$200 -$6 -1 -3%
UBS Group
20
UBS Group
Switzerland
– -$64.8K -10,696 Closed
GC
21
Gilbert & Cook
Iowa
– -$60.6K -10,000 Closed

COYA Hedge Fund Activity: Q3 2024 in Review

19 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q3 2024, worth a combined $21.4M — up 8% from $19.8M a quarter earlier.

Fund positioning in COYA was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 6 trimmed.

The largest buyer was CM Management, adding an estimated $278K. The largest seller was Royal Bank of Canada, cutting an estimated $68.1K.

  • 19 institutional investors held Coya Therapeutics (COYA) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $21.4M of Coya Therapeutics stock for Q3 2024, up 8% quarter-over-quarter.
  • 2 funds opened new Coya Therapeutics positions in Q3 2024 and 2 closed out, a net change of 0 holders.
  • The largest Coya Therapeutics buyer in Q3 2024 was CM Management, an estimated $278K added.
  • The largest Coya Therapeutics seller in Q3 2024 was Royal Bank of Canada, an estimated $68.1K sold.

Based on aggregated 13F filings for Q3 2024.